Sources | Names Used |
---|---|
GDSC1000 | KIN001-260 |
PharmacoGx | KIN001-260 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LYRM1 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.05 |
mRNA | PPP4C | GDSC1000 | pan-cancer | AAC | -0.06 | 0.05 |
mRNA | HTT | GDSC1000 | pan-cancer | AAC | 0.061 | 0.05 |
mRNA | TCF7 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.05 |
mRNA | VAX1 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
mRNA | SLC45A3 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.05 |
mRNA | CCR1 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.05 |
mRNA | MAPRE2 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
mRNA | S1PR4 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.05 |
mRNA | RRM1 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.05 |